(MedHeadlines) – Canadian researchers have found that maternal multiple sclerosis (MS) is generally not associated with adverse delivery outcomes or risk to their offspring. Full findings now appear in Annals of Neurology, a journal published by …

DURHAM, N.C. — Duke University Medical Center scientists have figured out which type of B cells act — and at what time — to keep a multiple-sclerosis (MS)-like disease under control, knowledge that will help …

In what’s been called a complete about-face, the US Food and Drug Administration (FDA) has issued a statement saying metal dental fillings, which are about half mercury, may lead to health problems in vulnerable individuals …

Although most commonly known as an effective antidepressant medication, fluoxetine, marketed under the brand name Prozac, was shown to be effective in slowing the progression of the relapsing remitting type of multiple sclerosis (MS), with …

Italian researchers have just announced the impressive findings of a study using an oral medication to combat attacks of the disease and prolong the time between relapses.  The most effective drugs used today – beta …

A multinational study of the effects of smoking cigarettes on the people of China has led to the alarming conclusion that smokers face serious risk of stroke, with the risk increasing the longer and heavier …

A study reported in the Feb. 14, 2008 issue of the New England Journal of Medicine, showed that a drug therapy currently used to treat non-Hodgkin’s lymphoma and rheumatoid arthritis had a significant effect in …